Screener
Alamar Biosciences ALMR Income Statement
| Q1 '26 | ||
|---|---|---|
| $26.04M+98.9% | ||
| $11.58M+72.8% | ||
| $14.46M+126% | ||
| 55.5%+6.7pp | ||
| $13.02M+56.8% | ||
| $13.79M+108% | ||
| $26.8M+79.4% | ||
| -$12.35M-44.4% | ||
| -47.4%+17.9pp | ||
| $223K+385% | ||
| -$20.86M-172% | ||
| $464K— | ||
| -$21.33M-178% | ||
| -81.9%-23.4pp | ||
| -$1.74-156% | ||
| -$11.18M-45.9% | ||
| -42.9%+15.6pp | ||
| -$12.35M-44.4% |
FAQ
- Where does Alamar Biosciences's income statement data come from?
- Every line is extracted from Alamar Biosciences's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.